Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer

被引:1
|
作者
Li, Zheng [1 ]
Sergent, Fabrice [2 ]
Bolla, Michel [3 ]
Zhou, Yunfeng [1 ]
Gabelle-Flandin, Isabelle [3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Dept Radiat & Med Oncol, Wuhan 430071, Hubei, Peoples R China
[2] Grenoble Univ, Cent Hosp, Dept Gynecol, F-38043 Grenoble, France
[3] Grenoble Univ, Cent Hosp, Dept Radiat Oncol, F-38043 Grenoble, France
关键词
breast cancer; radiotherapy; contralateral breast cancer; risk factors; RADIATION-THERAPY; POSTMENOPAUSAL WOMEN; CONSERVING SURGERY; CLINICAL UTILITY; RISK; TAMOXIFEN; PAI-1; UPA; EPIDEMIOLOGY; BRCA1;
D O I
10.3892/ol.2014.2623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate the therapeutic outcome of early-stage breast cancer (pT1aN0M0) and to identify prognostic factors for secondary primary contralateral breast cancer (CBC). A total of 85 patients with mammary carcinomas were included. All patients had undergone breast surgery and adjuvant treatment between January 2001 and December 2008 at the Central Hospital of Grenoble University (Grenoble, France). The primary end-points were disease-free survival and secondary CBC, and the potential prognostic factors were investigated. During a median follow-up of 60 months, 10 of the 85 patients presented with secondary primary cancer, of which six suffered with CBC. No patient mortalities were reported. The rates of CBC were 2.35, 3.53 and 7.06% at one, two and five years, respectively. The cumulative univariate analysis showed that microinvasion and family history are potential risk factors for newly CBC. The current study also demonstrated that secondary CBC was more likely to occur in patients with microinvasion or a family history of hte dise. In addition, the systematic treatment of secondary CBC should include hormone therapy.
引用
收藏
页码:245 / 251
页数:7
相关论文
共 50 条
  • [21] Preoperative breast MRI in early-stage breast cancer
    Young, Patricia
    Kim, Benjamin
    Malin, Jennifer L.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 135 (03) : 907 - 912
  • [22] Geographical Differences in Primary Therapy for Early-Stage Breast Cancer
    David I. Gregorio
    Martin Kulldorff
    Leah Barry
    Holly Samocuik
    Kristin Zarfos
    Annals of Surgical Oncology, 2001, 8 : 844 - 849
  • [23] Denosumab in early-stage breast cancer
    Brandao, Mariana
    Debiasi, Marcio
    de Azambuja, Evandro
    LANCET ONCOLOGY, 2019, 20 (05): : E234 - E235
  • [24] Early-Stage Breast Cancer Detection in Breast Milk
    Saura, Cristina
    Ortiz, Carolina
    Matito, Judit
    Arenas, Enrique J.
    Sunol, Anna
    Martin, Agatha
    Cordoba, Octavi
    Martinez-Sabadell, Alex
    Garcia-Ruiz, Itziar
    Miranda, Ignacio
    Morales-Comas, Clara
    Carrasco, Estela
    Viaplana, Cristina
    Peg, Vicente
    Nuciforo, Paolo
    Bayo-Puxan, Neus
    Gonzalez-Medina, Alberto
    Miquel, Josep M.
    Gomez-Rey, Marina
    Villacampa, Guillermo
    Arevalo, Silvia
    Espinosa-Bravo, Martin
    Balmana, Judith
    Dienstmann, Rodrigo
    Arribas, Joaquin
    Tabernero, Josep
    Vivancos, Ana
    Sanso, Miriam
    CANCER DISCOVERY, 2023, 13 (10) : 2180 - 2191
  • [25] Obesity and early-stage breast cancer
    Chlebowski, RT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1345 - 1347
  • [26] Partial breast radiation for early-stage breast cancer
    McCormick, Beryl
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (01) : 31 - 37
  • [27] Preoperative breast MRI in early-stage breast cancer
    Patricia Young
    Benjamin Kim
    Jennifer L. Malin
    Breast Cancer Research and Treatment, 2012, 135 : 907 - 912
  • [28] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Marilyn L. Kwan
    Jiaxiao M. Shi
    Laurel A. Habel
    Jun Song
    Joanie W-L Chung
    Chantal C. Avila
    Joanne E. Schottinger
    T. Craig Cheetham
    Suzanne W. Fletcher
    Reina Haque
    Breast Cancer Research and Treatment, 2016, 156 : 379 - 389
  • [29] Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen
    Kwan, Marilyn L.
    Shi, Jiaxiao M.
    Habel, Laurel A.
    Song, Jun
    Chung, Joanie W-L
    Avila, Chantal C.
    Schottinger, Joanne E.
    Cheetham, T. Craig
    Fletcher, Suzanne W.
    Haque, Reina
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 156 (02) : 379 - 389
  • [30] Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer
    Jeffrey E. Gershenwald
    Kelly K. Hunt
    Stephen S. Kroll
    Merrick I. Ross
    Bonnie J. Baldwin
    Barry W. Feig
    Frederick C. Ames
    Mark A. Schusterman
    S. Eva Singletary
    Annals of Surgical Oncology, 1998, 5 : 529 - 538